Total Payments
$267,525
2024 Payments
$663.58
Companies
45
Transactions
947
Medicare Patients
1,021
Medicare Billing
$245,606
Payment Breakdown by Category
Other$184,929 (69.1%)
Consulting$31,839 (11.9%)
Travel$26,698 (10.0%)
Food & Beverage$20,694 (7.7%)
Research$3,366 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $103,759 | 66 | 38.8% |
| Honoraria | $81,170 | 47 | 30.3% |
| Consulting Fee | $31,839 | 15 | 11.9% |
| Travel and Lodging | $26,698 | 116 | 10.0% |
| Food and Beverage | $20,694 | 681 | 7.7% |
| Unspecified | $3,366 | 22 | 1.3% |
Payments by Type
General
$264,160
925 transactions
Research
$3,366
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $100,006 | 218 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $43,255 | 93 | $0 (2021) |
| US WorldMeds, LLC | $42,946 | 170 | $0 (2020) |
| Lundbeck LLC | $33,694 | 112 | $0 (2022) |
| Amneal Pharmaceuticals LLC | $18,433 | 37 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $10,332 | 22 | $0 (2021) |
| MDD US Operations, LLC | $4,814 | 9 | $0 (2024) |
| ABBVIE INC. | $4,021 | 46 | $0 (2022) |
| Acorda Therapeutics, Inc | $2,451 | 10 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $1,918 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $663.58 | 10 | Merz Pharmaceuticals, LLC ($269.01) |
| 2023 | $639.55 | 6 | ACADIA Pharmaceuticals Inc ($473.30) |
| 2022 | $29,138 | 96 | ACADIA Pharmaceuticals Inc ($23,412) |
| 2021 | $41,980 | 144 | ACADIA Pharmaceuticals Inc ($23,848) |
| 2020 | $45,685 | 162 | ACADIA Pharmaceuticals Inc ($17,078) |
| 2019 | $67,450 | 225 | ACADIA Pharmaceuticals Inc ($21,229) |
| 2018 | $56,837 | 174 | Adamas Pharmaceuticals, Inc. ($23,805) |
| 2017 | $25,132 | 130 | Lundbeck LLC ($13,705) |
All Payment Transactions
947 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROLOGY | ||||||
| 09/30/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROLOGY | ||||||
| 07/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/15/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $140.81 | General |
| Category: Musculoskeletal | ||||||
| 07/03/2024 | MDD US Operations, LLC | — | Food and Beverage | In-kind items and services | $21.76 | General |
| 06/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $128.20 | General |
| Category: Musculoskeletal | ||||||
| 06/21/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: NEUROLOGY | ||||||
| 06/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $116.12 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/07/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROLOGY | ||||||
| 02/08/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $71.43 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: General - DBS_NMD | ||||||
| 08/08/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.31 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/08/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.31 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/07/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/07/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/27/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $116.25 | General |
| Category: Immunology | ||||||
| 11/03/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $91.57 | General |
| Category: Neuroscience | ||||||
| 11/03/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.65 | General |
| Category: Neuroscience | ||||||
| 09/07/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: Neuroscience | ||||||
| 07/27/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: Neuroscience | ||||||
| 06/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2022 | Acorda Therapeutics, Inc | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 05/27/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug) | Food and Beverage | Cash or cash equivalent | $73.58 | General |
| Category: Neuropsychiatry | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-063 | ACADIA Pharmaceuticals Inc | $1,275 | 12 |
| M15-741 | AbbVie, Inc. | $815.25 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 242 | 369 | $78,950 | $32,977 |
| 2021 | 8 | 395 | 957 | $212,150 | $102,696 |
| 2020 | 8 | 384 | 5,648 | $247,905 | $109,932 |
Total Patients
1,021
Total Services
6,974
Medicare Billing
$245,606
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 279 | $55,800 | $23,226 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 44 | $11,000 | $5,985 | 54.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $8,400 | $2,042 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 25 | $3,750 | $1,725 | 46.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 204 | 707 | $141,400 | $71,114 | 50.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 53 | 72 | $18,000 | $10,249 | 56.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 57 | 57 | $22,800 | $10,114 | 44.4% |
| 64611 | Injection of chemical for destruction of salivary glands on both sides of the mouth | Office | 2021 | 14 | 43 | $15,050 | $4,710 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $6,600 | $2,972 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 27 | $4,050 | $1,998 | 49.3% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 11 | 14 | $3,500 | $1,117 | 31.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 14 | 15 | $750.00 | $420.15 | 56.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 181 | 701 | $140,200 | $57,900 | 41.3% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2020 | 17 | 1,625 | $24,375 | $15,462 | 63.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 11 | 3,100 | $24,180 | $15,043 | 62.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 43 | 43 | $17,200 | $6,154 | 35.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 55 | $13,750 | $5,541 | 40.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 72 | $10,800 | $4,134 | 38.3% |
| 64611 | Injection of chemical for destruction of salivary glands on both sides of the mouth | Office | 2020 | 15 | 36 | $12,600 | $3,761 | 29.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,800 | $1,938 | 40.4% |
About Dr. Nisha Chhabria, MD
Dr. Nisha Chhabria, MD is a Neurology healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952421398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nisha Chhabria, MD has received a total of $267,525 in payments from pharmaceutical and medical device companies, with $663.58 received in 2024. These payments were reported across 947 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,759).
As a Medicare-enrolled provider, Chhabria has provided services to 1,021 Medicare beneficiaries, totaling 6,974 services with total Medicare billing of $245,606. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location West Palm Beach, FL
- Active Since 03/30/2007
- Last Updated 08/05/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1952421398
Products in Payments
- NUPLAZID (Drug) $100,006
- GOCOVRI (Drug) $43,755
- NORTHERA (Drug) $33,529
- Xadago (Drug) $21,576
- RYTARY (Drug) $18,337
- APOKYN (Drug) $12,137
- MYOBLOC (Biological) $8,706
- LATUDA (Drug) $5,978
- KYNMOBI (Drug) $4,043
- INBRIJA (Drug) $2,428
- INGREZZA (Drug) $1,731
- Infinity DBS Pulse Generators (Device) $769.79
- Neupro (Drug) $425.54
- AJOVY (Biological) $332.65
- NOURIANZ (Drug) $273.37
- Xeomin (Biological) $269.01
- ZEPOSIA (Drug) $232.91
- NAMZARIC (Drug) $195.64
- AUBAGIO (Drug) $168.60
- VALTOCO (Drug) $166.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in West Palm Beach
Arnaldo Da Silva, Md, MD
Neurology — Payments: $189,267
Neurology $189,267
Ali Malek, M.d, M.D
Neurology — Payments: $170,038
Neurology $170,038
Pedro Hernandez-Frau, M.d, M.D
Neurology — Payments: $61,313
Neurology $61,313
Carl Sadowsky, Md, MD
Neurology — Payments: $57,814
Neurology $57,814
Ms. Paayal Patel, M.d, M.D
Neurology — Payments: $34,817
Neurology $34,817
James Ghattas, Do, DO
Neurology — Payments: $17,191
Neurology $17,191